WPRIM Management System> DCMS> Blood Research> 2019> 54> 2

Volume: 54 Issue: 2

1. Erratum: Evaluation of thrombocytopenia in the hematology clinic: a case series from a large tertiary care center Page:158—158
2. Erratum: Breast implant-associated anaplastic large cell lymphoma Page:157—157
3. What is the most appropriate regimen for untreated Waldenström macroglobulinemia? Page:153—156
4. First case report of latent tuberculosis reactivation complicating treatment with nilotinib in chronic myeloid leukemia Page:151—153
5. False elevations of vitamin B12 levels due to assay errors in a patient with pernicious anemia Page:149—151
6. An investigation of methylation pattern changes in the IKZF1 promoter in patients with childhood B-cell acute lymphoblastic leukemia Page:144—148
7. Comparison of quality of life and depression between hematopoietic stem cell transplantation survivors and their spouse caregivers Page:137—143
8. Treatment of autoimmune hemolytic anemia: real world data from a reference center in Mexico Page:131—136
9. The top 10 things to know about transfusion medicine before intern year: an evidence-based course for graduating medical students Page:125—130
10. Determining the risk factors associated with the development of Clostridium difficile infection in patients with hematological diseases Page:120—124
11. Clinical significance of cell-free DNA as a prognostic biomarker in patients with diffuse large B-cell lymphoma Page:114—119
12. Safety and efficacy of bendamustine in the conditioning regimen for autologous stem cell transplantation in patients with relapsed/refractory lymphoma Page:108—113
13. Enhanced polo-like kinase 1 expression in myelodysplastic syndromes Page:102—107
14. Role of redox iron towards an increase in mortality among patients: a systemic review and meta-analysis Page:87—101
15. Evans syndrome diagnosed after traumatic subdural hemorrhage Page:86—86
16. Simultaneous presentation of plasma cell myeloma and hairy cell leukemia Page:85—85
17. Follicular lymphoma with prominent Dutcher body formation after liver transplantation Page:84—84
18. Chimeric antigen T cell receptor treatment in hematological malignancies Page:81—83